Related Experiment Videos
[Acute leukemias in adulthood--cure in sight?].
Schweizerische Medizinische Wochenschrift
|September 10, 1983
Summary
Treatment for adult acute leukemia has improved by tailoring strategies to disease subtypes. Intensive chemotherapy is crucial for acute myelocytic leukemia, while acute lymphocytic leukemia responds better to less aggressive approaches, leading to higher remission rates.
Area of Science:
- Hematology
- Oncology
Context:
- Acute leukemia treatment has advanced due to a deeper understanding of disease heterogeneity.
- Therapeutic strategies are increasingly adapted to specific leukemia subtypes.
Purpose:
- To outline current therapeutic strategies for adult acute leukemias, differentiating between acute myelocytic leukemia and acute lymphocytic leukemia.
- To highlight the importance of tailored treatment approaches for optimizing patient outcomes.
Summary:
- For acute myelocytic leukemia (AML), intensive multi-drug chemotherapy is required to achieve complete remission (CR) in approximately 75% of patients under 65, with a high recurrence rate necessitating consideration of bone marrow transplantation during first CR.
- Acute lymphocytic leukemia (ALL) demonstrates higher chemotherapy sensitivity, with less aggressive induction and maintenance therapy achieving CR in up to 85% of patients, many achieving long-term remission or cure.
Impact:
- Optimized treatment protocols for AML and ALL improve complete remission rates and long-term outcomes.
- Early consideration of bone marrow transplantation in AML can improve survival for relapsed patients.
- Advancements in chemotherapy and supportive care enhance patient management during intensive treatment phases.